Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 866

1.

Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?

Ancedy Y, Berthelot E, Lang S, Ederhy S, Boyer-Chatenet L, Di Angelantonio E, Soulat-Dufour L, Etienney A, Adavane-Scheublé S, Boccara F, Cohen A.

Arch Cardiovasc Dis. 2018 May;111(5):357-369. doi: 10.1016/j.acvd.2017.08.004.

PMID:
29685722
2.

Effect of atrial fibrillation duration on plasma von Willebrand factor level.

Wysokinski WE, Cohoon KP, Konik EA, Melduni RM, Ammash NM, Asirvatham SJ, McBane RD.

Eur J Haematol. 2017 Dec;99(6):569-576. doi: 10.1111/ejh.12975. Epub 2017 Oct 16.

PMID:
28952167
3.

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Lavin M, Aguila S, Schneppenheim S, Dalton N, Jones KL, O'Sullivan JM, O'Connell NM, Ryan K, White B, Byrne M, Rafferty M, Doyle MM, Nolan M, Preston RJS, Budde U, James P, Di Paola J, O'Donnell JS.

Blood. 2017 Nov 23;130(21):2344-2353. doi: 10.1182/blood-2017-05-786699. Epub 2017 Sep 15.

PMID:
28916584
4.

Stasis Promotes Erythrocyte Adhesion to von Willebrand Factor.

Smeets MWJ, Mourik MJ, Niessen HWM, Hordijk PL.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1618-1627. doi: 10.1161/ATVBAHA.117.309885. Epub 2017 Aug 3.

PMID:
28775074
5.

A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.

Deng W, Wang Y, Druzak SA, Healey JF, Syed AK, Lollar P, Li R.

J Thromb Haemost. 2017 Sep;15(9):1867-1877. doi: 10.1111/jth.13775. Epub 2017 Aug 9.

6.

Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis.

Bettoni S, Galbusera M, Gastoldi S, Donadelli R, Tentori C, Spartà G, Bresin E, Mele C, Alberti M, Tortajada A, Yebenes H, Remuzzi G, Noris M.

J Immunol. 2017 Aug 1;199(3):1021-1040. doi: 10.4049/jimmunol.1601121. Epub 2017 Jun 26.

7.

Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.

Reich HJ, Morgan J, Arabia F, Czer L, Moriguchi J, Ramzy D, Esmailian F, Lam L, Dunhill J, Volod O.

J Thromb Haemost. 2017 Aug;15(8):1620-1624. doi: 10.1111/jth.13753. Epub 2017 Jul 5.

PMID:
28586149
8.

vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology.

Muuronen AT, Taina M, Onatsu J, Korhonen M, Pulkki K, Jäkälä P, Vanninen R, Mustonen P.

PLoS One. 2017 Jun 1;12(6):e0178508. doi: 10.1371/journal.pone.0178508. eCollection 2017.

9.

Clinical and laboratory phenotype variability in type 2M von Willebrand disease.

Doruelo AL, Haberichter SL, Christopherson PA, Boggio LN, Gupta S, Lentz SR, Shapiro AD, Montgomery RR, Flood VH.

J Thromb Haemost. 2017 Aug;15(8):1559-1566. doi: 10.1111/jth.13742. Epub 2017 Jun 23.

10.

Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping.

Tischer A, Machha VR, Frontroth JP, Brehm MA, Obser T, Schneppenheim R, Mayne L, Walter Englander S, Auton M.

J Mol Biol. 2017 Jul 7;429(14):2161-2177. doi: 10.1016/j.jmb.2017.05.013. Epub 2017 May 19.

11.

Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association With Risk for Recurrent Stroke.

Williams SR, Hsu FC, Keene KL, Chen WM, Dzhivhuho G, Rowles JL 3rd, Southerland AM, Furie KL, Rich SS, Worrall BB, Sale MM; GARNET (The Genomics and Randomized Trials Network) Collaborative Research Group.

Stroke. 2017 Jun;48(6):1444-1450. doi: 10.1161/STROKEAHA.116.015677. Epub 2017 May 11.

12.

Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.

Bowman ML, Pluthero FG, Tuttle A, Casey L, Li L, Christensen H, Robinson KS, Lillicrap D, Kahr WHA, James P.

J Thromb Haemost. 2017 Jul;15(7):1403-1411. doi: 10.1111/jth.13722. Epub 2017 Jun 6.

13.

The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.

Rautio A, Boman K, Gerstein HC, Hernestål-Boman J, Lee SF, Olofsson M, Mellbin LG.

Diab Vasc Dis Res. 2017 Jul;14(4):345-352. doi: 10.1177/1479164117703034. Epub 2017 Apr 12.

PMID:
28403644
14.

Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.

Feldmann C, Zayat R, Goetzenich A, Aljalloud A, Woelke E, Maas J, Tewarie L, Schmitz-Rode T, Autschbach R, Steinseifer U, Moza A.

PLoS One. 2017 Feb 24;12(2):e0171029. doi: 10.1371/journal.pone.0171029. eCollection 2017.

15.

Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.

Tati R, Kristoffersson AC, Manea Hedström M, Mörgelin M, Wieslander J, van Kooten C, Karpman D.

EBioMedicine. 2017 Feb;16:302-311. doi: 10.1016/j.ebiom.2017.01.032. Epub 2017 Jan 24.

16.

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

García-Fernández A, Roldán V, Rivera-Caravaca JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.

Sci Rep. 2017 Jan 30;7:41565. doi: 10.1038/srep41565.

17.

Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin.

Mojiri A, Stoletov K, Carrillo MA, Willetts L, Jain S, Godbout R, Jurasz P, Sergi CM, Eisenstat DD, Lewis JD, Jahroudi N.

Oncotarget. 2017 Feb 21;8(8):13015-13029. doi: 10.18632/oncotarget.14273.

18.

N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.

O'Sullivan JM, Aguila S, McRae E, Ward SE, Rawley O, Fallon PG, Brophy TM, Preston RJ, Brady L, Sheils O, Chion A, O'Donnell JS.

J Thromb Haemost. 2016 Dec;14(12):2446-2457. doi: 10.1111/jth.13537. Epub 2016 Dec 9.

PMID:
27732771
19.

Biophysical approaches promote advances in the understanding of von Willebrand factor processing and function.

Löf A, Müller JP, Benoit M, Brehm MA.

Adv Biol Regul. 2017 Jan;63:81-91. doi: 10.1016/j.jbior.2016.09.010. Epub 2016 Sep 28. Review.

PMID:
27717713
20.

Intron retention resulting from a silent mutation in the VWF gene that structurally influences the 5' splice site.

Yadegari H, Biswas A, Akhter MS, Driesen J, Ivaskevicius V, Marquardt N, Oldenburg J.

Blood. 2016 Oct 27;128(17):2144-2152. Epub 2016 Aug 19.

Supplemental Content

Support Center